About DNAnexus
DNAnexus is a company based in Mountain View (United States) founded in 2009.. DNAnexus has raised $472.55 million across 11 funding rounds from investors including Regeneron Pharmaceuticals, Blackstone and TPG. DNAnexus offers products and services including DNAnexus Platform, Bioinformatics Tools, and Collaboration Services. DNAnexus operates in a competitive market with competitors including Cytel, Genomics, Seven Bridges Genomics, Metagenomi and Ampersand, among others.
- Headquarter Mountain View, United States
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Dnanexus, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$472.55 M (USD)
in 11 rounds
-
Latest Funding Round
$200 M (USD), Series H
Mar 08, 2022
-
Investors
Regeneron Pharmaceuticals
& 17 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DNAnexus
DNAnexus offers a comprehensive portfolio of products and services, including DNAnexus Platform, Bioinformatics Tools, and Collaboration Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Cloud-based tool for organizing and analyzing omics datasets securely.
Suite of apps for processing and visualizing genomic data efficiently.
Environment for team-based data sharing and compliance management.
Unlock access to complete
Unlock access to complete
Software Development Team
53 people
Leadership Team
21 people
Senior Team
11 people
Principal Team
8 people
Product Management Team
7 people
Sales and Marketing
6 people
Human Resources and Administration
5 people
Finance and Accounting
4 people
Unlock access to complete
Funding Insights of DNAnexus
DNAnexus has successfully raised a total of $472.55M across 11 strategic funding rounds. The most recent funding activity was a Series H round of $200 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series H — $200.0M
-
First Round
First Round
(28 Jul 2009)
- Investors Count 18
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Series H - DNAnexus | Valuation | Blackstone | |
| Jun, 2020 | Amount | Series G - DNAnexus | Valuation | Perceptive Advisors , Northpond Ventures | |
| Feb, 2019 | Amount | Debt – Conventional - DNAnexus | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DNAnexus
DNAnexus has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include Regeneron Pharmaceuticals, Blackstone and TPG. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified investment management is provided across multiple asset classes.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life sciences & tech sectors
|
Founded Year | Domain | Location | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DNAnexus
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DNAnexus
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dnanexus Comparisons
Competitors of DNAnexus
DNAnexus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytel, Genomics, Seven Bridges Genomics, Metagenomi and Ampersand, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
Genomic risk assessment and prevention platform is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| domain | founded_year | HQ Location |
Next-generation gene editing tools are developed for drug enhancement.
|
|
| domain | founded_year | HQ Location |
Programmable medicines are developed to target and treat multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dnanexus
Frequently Asked Questions about DNAnexus
When was DNAnexus founded?
DNAnexus was founded in 2009.
Where is DNAnexus located?
DNAnexus is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Who is the current CEO of DNAnexus?
Richard Daly is the current CEO of DNAnexus.
Is DNAnexus a funded company?
DNAnexus is a funded company, having raised a total of $472.55M across 11 funding rounds to date.
What does DNAnexus do?
DNAnexus was founded in 2009 and is headquartered in Mountain View, United States. Tools for cloud-based genome informatics and data management are offered to enterprises involved in genomic medicine. Raw sequencing data is analyzed through the platform, while genomic information is integrated with clinical and phenotypic data. Seamless collaboration among organizations is facilitated in this sector.
Who are the top competitors of DNAnexus?
DNAnexus's top competitors include Cytel, Metagenomi and Ampersand.
What products or services does DNAnexus offer?
DNAnexus offers DNAnexus Platform, Bioinformatics Tools, and Collaboration Services.
Who are DNAnexus's investors?
DNAnexus has 18 investors. Key investors include Regeneron Pharmaceuticals, Blackstone, TPG, HHS, and MidCap Financial.
What is DNAnexus's valuation?
The valuation of DNAnexus is $600M as of Mar 2022.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.